Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikas Gupta

Showing results (641-650 of 792) with videos related to

Pageof 80
Sort By:
British Journal of Haematology|June 16, 2021
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort studyAniket Bankar, Shabbir Alibhai, Elliot Smith, et al.
Plant Physiology and Biochemistry : PPB|December 3, 2024
Do different wheat ploidy levels respond differently against stripe rust infection: Interplay between reactive oxygen species (ROS) and the antioxidant defense system?Farkhandah Jan, Parthiban M, Satinder Kaur, et al.
British Journal of Haematology|April 7, 2009
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantationVoravit Ratanatharathorn, Brent Logan, Dan Wang, et al.
Cancer Medicine|October 14, 2016
A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemiaGregory A Reed, Gary J Schiller, Suman Kambhampati, et al.
Leukemia & Lymphoma|March 19, 2024
Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trialVikas Gupta, Stephen Oh, Timothy Devos, et al.
Haematologica|January 4, 2020
Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemiaRobert Puckrin, Eshetu G Atenafu, Jaime O Claudio, et al.
Journal of Clinical and Experimental Hepatology|February 23, 2024
Outcomes of Self-expandable Metal Stents in Patients With Unresectable Gallbladder Cancer Undergoing Percutaneous Biliary DrainagePavithra Subramanian, Mukul Morya, Pankaj Gupta, et al.
The Lancet Regional Health. Southeast Asia|May 17, 2024
Deep-learning enabled ultrasound based detection of gallbladder cancer in northern India: a prospective diagnostic studyPankaj Gupta, Soumen Basu, Pratyaksha Rana, et al.
Frontiers in Oncology|July 12, 2023
Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemiaAnne Tierens, Elizabeth Kagotho, Satoru Shinriki, et al.
Infection Control and Hospital Epidemiology|September 5, 2020
Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance dataDavid A Butler, Mark Biagi, Vikas Gupta, et al.
Pageof 80

Showing results (641-650 of 792) with videos related to

Sort By:
Pageof 80
British Journal of Haematology|June 16, 2021
Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort studyAniket Bankar, Shabbir Alibhai, Elliot Smith, et al.
Plant Physiology and Biochemistry : PPB|December 3, 2024
Do different wheat ploidy levels respond differently against stripe rust infection: Interplay between reactive oxygen species (ROS) and the antioxidant defense system?Farkhandah Jan, Parthiban M, Satinder Kaur, et al.
British Journal of Haematology|April 7, 2009
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantationVoravit Ratanatharathorn, Brent Logan, Dan Wang, et al.
Cancer Medicine|October 14, 2016
A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemiaGregory A Reed, Gary J Schiller, Suman Kambhampati, et al.
Leukemia & Lymphoma|March 19, 2024
Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trialVikas Gupta, Stephen Oh, Timothy Devos, et al.
Haematologica|January 4, 2020
Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemiaRobert Puckrin, Eshetu G Atenafu, Jaime O Claudio, et al.
Journal of Clinical and Experimental Hepatology|February 23, 2024
Outcomes of Self-expandable Metal Stents in Patients With Unresectable Gallbladder Cancer Undergoing Percutaneous Biliary DrainagePavithra Subramanian, Mukul Morya, Pankaj Gupta, et al.
The Lancet Regional Health. Southeast Asia|May 17, 2024
Deep-learning enabled ultrasound based detection of gallbladder cancer in northern India: a prospective diagnostic studyPankaj Gupta, Soumen Basu, Pratyaksha Rana, et al.
Frontiers in Oncology|July 12, 2023
Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemiaAnne Tierens, Elizabeth Kagotho, Satoru Shinriki, et al.
Infection Control and Hospital Epidemiology|September 5, 2020
Development of a 51-hospital Chicagoland regional antibiogram and comparison to local hospital and national surveillance dataDavid A Butler, Mark Biagi, Vikas Gupta, et al.
Pageof 80